Operating Lease, Right-of-Use Asset of Avid Bioservices, Inc. from 30 Apr 2019 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Avid Bioservices, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Apr 2019 to 31 Oct 2024.
  • Avid Bioservices, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Oct 2024 was $40,321,000, a 3.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Avid Bioservices, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $40,321,000 -$1,652,000 -3.9% 31 Oct 2024 10-Q 10 Dec 2024 2025 Q2
Q2 2024 $40,741,000 -$1,633,000 -3.9% 31 Jul 2024 10-Q 09 Sep 2024 2025 Q1
Q1 2024 $41,157,000 -$1,615,000 -3.8% 30 Apr 2024 10-Q 10 Dec 2024 2025 Q2
Q4 2023 $41,567,000 +$7,104,000 +21% 31 Jan 2024 10-Q 24 Apr 2024 2024 Q3
Q3 2023 $41,973,000 +$6,600,000 +19% 31 Oct 2023 10-Q/A 24 Apr 2024 2024 Q2
Q2 2023 $42,374,000 +$6,281,000 +17% 31 Jul 2023 10-Q/A 24 Apr 2024 2024 Q1
Q1 2023 $42,772,000 +$5,966,000 +16% 30 Apr 2023 10-K 02 Jul 2024 2024 FY
Q4 2022 $34,463,000 -$3,045,000 -8.1% 31 Jan 2023 10-K/A 24 Apr 2024 2023 FY
Q3 2022 $35,373,000 -$2,850,000 -7.5% 31 Oct 2022 10-K/A 24 Apr 2024 2023 FY
Q2 2022 $36,093,000 +$13,216,000 +58% 31 Jul 2022 10-K/A 24 Apr 2024 2023 FY
Q1 2022 $36,806,000 +$18,115,000 +97% 30 Apr 2022 10-K/A 24 Apr 2024 2023 FY
Q4 2021 $37,508,000 +$18,455,000 +97% 31 Jan 2022 10-Q 08 Mar 2022 2022 Q3
Q3 2021 $38,223,000 +$18,815,000 +97% 31 Oct 2021 10-Q 07 Dec 2021 2022 Q2
Q2 2021 $22,877,000 +$3,120,000 +16% 31 Jul 2021 10-Q 08 Sep 2021 2021 Q1
Q1 2021 $18,691,000 $0 0% 30 Apr 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 $19,053,000 -$1,384,000 -6.8% 31 Jan 2021 10-Q 08 Mar 2021 2021 Q3
Q3 2020 $19,408,000 -$1,973,000 -9.2% 31 Oct 2020 10-Q 02 Dec 2020 2021 Q2
Q2 2020 $19,757,000 -$2,844,000 -13% 31 Jul 2020 10-Q 01 Sep 2020 2021 Q1
Q1 2020 $18,691,000 +$18,691,000 30 Apr 2020 10-Q 08 Sep 2021 2021 Q1
Q4 2019 $20,437,000 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 $21,381,000 31 Oct 2019 10-Q 09 Dec 2019 2020 Q2
Q2 2019 $22,601,000 31 Jul 2019 10-Q 05 Sep 2019 2020 Q1
Q1 2019 $0 30 Apr 2019 10-K 30 Jun 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.